Yeast-derived nanoparticles remodel the immunosuppressive microenvironment in tumor and tumor-draining lymph nodes to suppress tumor growth
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Yeast-derived nanoparticles remodel the immunosuppressive microenvironment in tumor and tumor-draining lymph nodes to suppress tumor growth
Authors
Keywords
-
Journal
Nature Communications
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-01-10
DOI
10.1038/s41467-021-27750-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The impact of size on particle drainage dynamics and antibody response
- (2021) Simon Zinkhan et al. JOURNAL OF CONTROLLED RELEASE
- Intratumoral heterogeneity in cancer progression and response to immunotherapy
- (2021) Ilio Vitale et al. NATURE MEDICINE
- Innate cell microenvironments in lymph nodes shape the generation of T cell responses during type I inflammation
- (2021) Joseph M. Leal et al. Science Immunology
- Tumor-draining lymph nodes: At the crossroads of metastasis and immunity
- (2021) Haley du Bois et al. Science Immunology
- Polysaccharide-based nanomedicines for cancer immunotherapy: A review
- (2021) Yujun Zeng et al. Bioactive Materials
- Top 10 Challenges in Cancer Immunotherapy
- (2020) Priti S. Hegde et al. IMMUNITY
- Sugar-Nanocapsules Imprinted with Microbial Molecular Patterns for mRNA Vaccination
- (2020) Sejin Son et al. NANO LETTERS
- STING and IRF3 in stromal fibroblasts enable sensing of genomic stress in cancer cells to undermine oncolytic viral therapy
- (2020) Esther N. Arwert et al. NATURE CELL BIOLOGY
- Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy
- (2020) Maud Mayoux et al. Science Translational Medicine
- Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity
- (2020) Daniel S. Leventhal et al. Nature Communications
- Microbiome and cancer immunotherapy
- (2020) Shanmuga Reddy Chilakapati et al. CURRENT OPINION IN BIOTECHNOLOGY
- Effective combination immunotherapy using oncolytic viruses to deliver CAR targets to solid tumors
- (2020) Anthony K. Park et al. Science Translational Medicine
- Enhanced Potassium-Ion Storage of the 3D Carbon Superstructure by Manipulating the Nitrogen-Doped Species and Morphology
- (2020) Yanhua Li et al. Nano-Micro Letters
- Bacteria-triggered tumor-specific thrombosis to enable potent photothermal immunotherapy of cancer
- (2020) Xuan Yi et al. Science Advances
- An implantable blood clot–based immune niche for enhanced cancer vaccination
- (2020) Qin Fan et al. Science Advances
- SnapShot: Cancer Immunotherapy with Oncolytic Viruses
- (2019) Shashi Gujar et al. CELL
- Material design for lymph node drug delivery
- (2019) Alex Schudel et al. Nature Reviews Materials
- Yeast-Derived β-Glucan in Cancer: Novel Uses of a Traditional Therapeutic
- (2019) Anne Geller et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Programmable bacteria as cancer therapy
- (2019) Michael Dougan et al. NATURE MEDICINE
- Red blood cell–derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy
- (2019) Xiao Han et al. Science Advances
- Immunological impact of cell death signaling driven by radiation on the tumor microenvironment
- (2019) Maria Esperanza Rodriguez-Ruiz et al. NATURE IMMUNOLOGY
- Antioxidant, antiproliferative, and immunostimulatory effects of cell wall α- d -mannan fractions from Kluyveromyces marxianus
- (2018) Éder Galinari et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- (2018) Mikhail Binnewies et al. NATURE MEDICINE
- Potentiating prostate cancer immunotherapy with oncolytic viruses
- (2018) Patrick Lee et al. Nature Reviews Urology
- Role of PD-1 during effector CD8 T cell differentiation
- (2018) Eunseon Ahn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies
- (2018) Laurence Zitvogel et al. SCIENCE
- Optimizing Tumor Microenvironment for Cancer Immunotherapy: β-Glucan-Based Nanoparticles
- (2018) Mei Zhang et al. Frontiers in Immunology
- Interactions Between Nanoparticles and Dendritic Cells: From the Perspective of Cancer Immunotherapy
- (2018) Jianbo Jia et al. Frontiers in Oncology
- A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
- (2018) Miguel F. Sanmamed et al. CELL
- Two-step enhanced cancer immunotherapy with engineeredSalmonella typhimuriumsecreting heterologous flagellin
- (2017) Jin Hai Zheng et al. Science Translational Medicine
- Characterization and Optimization of the Glucan Particle-Based Vaccine Platform
- (2013) Haibin Huang et al. Clinical and Vaccine Immunology
- Immunization with Escherichia coli Outer Membrane Vesicles Protects Bacteria-Induced Lethality via Th1 and Th17 Cell Responses
- (2013) O. Y. Kim et al. JOURNAL OF IMMUNOLOGY
- Biodegradable Particles as Vaccine Delivery Systems: Size Matters
- (2012) Vijaya B. Joshi et al. AAPS Journal
- An Immunosurveillance Mechanism Controls Cancer Cell Ploidy
- (2012) L. Senovilla et al. SCIENCE
- The effects of β-glucan on human immune and cancer cells
- (2009) Godfrey Chan et al. Journal of Hematology & Oncology
- Percolation theory to predict effective properties of solid oxide fuel-cell composite electrodes
- (2009) Daifen Chen et al. JOURNAL OF POWER SOURCES
- Materials engineering for immunomodulation
- (2009) Jeffrey A. Hubbell et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More